| Authors: |
Palma LG; Program in Cancer Research. Hospital del Mar Research Institute, Barcelona, Spain.; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Alvarez-Villanueva D; Program in Cancer Research. Hospital del Mar Research Institute, Barcelona, Spain.; Institut Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobrega, Barcelona, Spain., Maqueda M; Program in Cancer Research. Hospital del Mar Research Institute, Barcelona, Spain.; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Barrero M; Centre for Genomic Regulationlation(CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain., Iglesias A; Program in Cancer Research. Hospital del Mar Research Institute, Barcelona, Spain.; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Bertran J; Universitat de Vic - Universitat Central de Catalunya, Vic, Spain., Alvarez D; Josep Carreras Leukemia Research Institute, Barcelona, Spain., Garcia-Prieto CA; Josep Carreras Leukemia Research Institute, Barcelona, Spain., Ballare C; Centre for Genomic Regulationlation(CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain., Rodriguez-Cortez V; Josep Carreras Leukemia Research Institute, Barcelona, Spain., Bueno C; Josep Carreras Leukemia Research Institute, Barcelona, Spain., Vidal A; Institut Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobrega, Barcelona, Spain., Villanueva A; Catalan Institute of Oncology (ICO/IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain., Menendez P; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Spanish Network for Advanced Therapies (RICORS-TERAV). Carlos III Health Institute (ISCIII), Madrid, Spain.; Department of Biomedicine. University of Barcelona, Barcelona, Spain.; Institucio Catalana de Recerca i Estudis Avançats(ICREA), Barcelona, Spain., Stik G; Josep Carreras Leukemia Research Institute, Barcelona, Spain., Di Croce L; Centre for Genomic Regulationlation(CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Institucio Catalana de Recerca i Estudis Avançats(ICREA), Barcelona, Spain.; Universitat Pompeu Fabra, Barcelona, Spain., Payer B; Centre for Genomic Regulationlation(CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Universitat Pompeu Fabra, Barcelona, Spain., Esteller M; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Institucio Catalana de Recerca i Estudis Avançats(ICREA), Barcelona, Spain.; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Barcelona, Spain., Espinosa L; Program in Cancer Research. Hospital del Mar Research Institute, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Bigas A; Program in Cancer Research. Hospital del Mar Research Institute, Barcelona, Spain.; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. |
